T. Rowe Price Associates’s Ortho Clinical Diagnostics Holdings plc Ordinary Shares OCDX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-19,489,153
| Closed | -$364M | – | 3026 |
|
|
2022
Q1 | $364M | Sell |
19,489,153
-492,505
| -2% | -$9.19M | 0.04% | 393 |
|
|
2021
Q4 | $427M | Buy |
19,981,658
+115,758
| +0.6% | +$2.48M | 0.04% | 374 |
|
|
2021
Q3 | $367M | Buy |
19,865,900
+4,069,037
| +26% | +$75.2M | 0.03% | 400 |
|
|
2021
Q2 | $338M | Sell |
15,796,863
-74,725
| -0.5% | -$1.6M | 0.03% | 428 |
|
|
2021
Q1 | $306M | Buy |
+15,871,588
| New | +$306M | 0.03% | 437 |
|